These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29105783)

  • 41. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
    Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An inhibitor peptide of toll-like receptor 2 shows therapeutic potential for allergic conjunctivitis.
    Xu C; He X; Liu W; Chen Y; Zhou C; Duan Z; Lu Q; Yan X; Zhang Z; Zheng R
    Int Immunopharmacol; 2017 May; 46():9-15. PubMed ID: 28246054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of human mast cell-derived cytokines in eosinophil biology.
    Shakoory B; Fitzgerald SM; Lee SA; Chi DS; Krishnaswamy G
    J Interferon Cytokine Res; 2004 May; 24(5):271-81. PubMed ID: 15153310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Histological study of allergic conjunctivitis--1. Study on the adhesion molecules to allergic conjunctivitis].
    Shoji J; Inada N; Takaura N; Sawa M
    Nippon Ganka Gakkai Zasshi; 1995 Feb; 99(2):129-34. PubMed ID: 7535507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Culture medium from TNF-α-stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms.
    Su W; Wan Q; Huang J; Han L; Chen X; Chen G; Olsen N; Zheng SG; Liang D
    J Allergy Clin Immunol; 2015 Aug; 136(2):423-32.e8. PubMed ID: 25652765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrosis in ocular allergic inflammation: recent concepts in the pathogenesis of ocular allergy.
    Solomon A; Puxeddu I; Levi-Schaffer F
    Curr Opin Allergy Clin Immunol; 2003 Oct; 3(5):389-93. PubMed ID: 14501440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
    Schopf L; Luccioli S; Bundoc V; Justice P; Chan CC; Wetzel BJ; Norris HH; Urban JF; Keane-Myers A
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune mechanisms in allergic eye diseases: what is new?
    Offiah I; Calder VL
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):477-81. PubMed ID: 19620858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgE and non-IgE mechanisms in ocular allergy.
    Bonini S; Bonini S
    Ann Allergy; 1993 Sep; 71(3):296-9. PubMed ID: 8373003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct in vivo monitoring of acute allergic reactions in human conjunctiva.
    Helintö M; Renkonen R; Tervo T; Vesaluoma M; Saaren-Seppälä H; Haahtela T; Kirveskari J
    J Immunol; 2004 Mar; 172(5):3235-42. PubMed ID: 14978131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model.
    Lee HS; Kwon JY; Joo CK
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging concepts: mast cell involvement in allergic diseases.
    Modena BD; Dazy K; White AA
    Transl Res; 2016 Aug; 174():98-121. PubMed ID: 26976119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic options in ocular allergic disease.
    Hingorani M; Lightman S
    Drugs; 1995 Aug; 50(2):208-21. PubMed ID: 8521755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical findings in prosthesis-associated giant papillary conjunctivitis.
    Bozkurt B; Akyurek N; Irkec M; Erdener U; Memis L
    Clin Exp Ophthalmol; 2007 Aug; 35(6):535-40. PubMed ID: 17760635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of Allergic Conjunctivitis Induced by House Dust Mite Extract From Dermatophagoides pteronyssinus.
    Lee YJ; Han SJ; Lee H; Kim JS; Seo KY
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1773-81. PubMed ID: 27074380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
    Lee HJ; Kim BM; Shin S; Kim TY; Chung SH
    Clin Immunol; 2017 Mar; 176():49-54. PubMed ID: 28063939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Restoring conjunctival tolerance by topical nuclear factor-κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice.
    Guzmán M; Sabbione F; Gabelloni ML; Vanzulli S; Trevani AS; Giordano MN; Galletti JG
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(9):6116-26. PubMed ID: 25190648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in pharmacotherapy for allergic conjunctivitis.
    Abelson MB; Shetty S; Korchak M; Butrus SI; Smith LM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1219-31. PubMed ID: 25943976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anti-inflammatory effects of therapies for ocular allergy.
    Mantelli F; Calder VL; Bonini S
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):786-93. PubMed ID: 24044620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Roles of cytokines in the development of severe allergic conjunctival diseases: analyses using animal models].
    Fukushima A
    Nippon Ganka Gakkai Zasshi; 2004 Nov; 108(11):682-9. PubMed ID: 15584353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.